510(k) K942501
K942501 is an FDA 510(k) premarket notification submitted by Schiapparelli Biosystems, Inc. for the device "ACE CEDIA PHENOBARBITAL ASSAY". The FDA issued a decision of Substantially Equivalent on October 6, 1994. The device falls under product code DLZ (Enzyme Immunoassay, Phenobarbital), a Class II device regulated under 21 CFR 862.3660. Schiapparelli Biosystems, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 6, 1994
- Date Received
- May 24, 1994
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Phenobarbital
- Device Class
- Class II
- Regulation Number
- 862.3660
- Review Panel
- TX
- Submission Type